Cross-cancer GWAS meta-analysis of more than 370,000 cases and 530,000 controls identifies multiple novel cancer risk regions

Autor: Lindstrom, S, Kar, S, Wang, L, Turman, C, MacDonald, J, Bammler, T, BCAC, OCAC, PRACTICAL, Huyghe, J, Schmit, S, O'Mara, TA, Thompson, DJ, Gharahkhani, P, MacGregor, S, Brennan, P, Houlston, RS, Melin, BS, Amos, CI, McKay, J, Iles, MM, Law, MH, Klein, A, Amundadottir, L, Pasaniuc, B, Pharoah, P, Hung, RJ, Kraft, P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ab1f702d60a9eda921c888d8699f6b05

Association between adult height, genetic susceptibility and risk of glioma.

Autor: Kitahara CM, Wang SS, Melin BS, Wang Z, Braganza M, Inskip PD, Albanes D, Andersson U, Beane Freeman LE, Buring JE, Carreón T, Feychting M, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Hankinson SE, Henriksson R, Hsing AW, Johansen C

Publikováno v: International Journal of Epidemiology; Aug2012, Vol. 41 Issue 4, p1075-1085, 11p

The genomic landscape of familial glioma.

Autor: Choi DJ; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Armstrong G; Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA., Lozzi B; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Vijayaraghavan P; Rady Children's Institute for Genomic Medicine, San Diego, CA, USA., Plon SE; Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, TX, USA., Wong TC; Rady Children's Institute for Genomic Medicine, San Diego, CA, USA., Boerwinkle E; The University of Texas Health Science Center School of Public Health, Houston, TX, USA., Muzny DM; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Chen HC; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Gibbs RA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Ostrom QT; Department of Neurosurgery, Duke University School of Medicine, Durham, NC, USA., Melin B; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Deneen B; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Bondy ML; Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA., Bainbridge MN; Rady Children's Institute for Genomic Medicine, San Diego, CA, USA., Amos CI, Barnholtz-Sloan JS, Bernstein JL, Claus EB, Houlston RS, Il'yasova D, Jenkins RB, Johansen C, Lachance D, Lai R, Melin BS, Merrell RT, Olson SH, Sadetzki S, Schildkraut J, Shete S, Ambrose JC, Arumugam P, Bevers R, Bleda M, Boardman-Pretty F, Boustred CR, Brittain H, Brown MA, Caulfield MJ, Chan GC, Giess A, Griffin JN, Hamblin A, Henderson S, Hubbard TJP, Jackson R, Jones LJ, Kasperaviciute D, Kayikci M, Kousathanas A, Lahnstein L, Lakey A, Leigh SEA, Leong IUS, Lopez FJ, Maleady-Crowe F, McEntagart M, Minneci F, Mitchell J, Moutsianas L, Mueller M, Murugaesu N, Need AC, O'Donovan P, Odhams CA, Patch C, Perez-Gil D, Pereira MB, Pullinger J, Rahim T, Rendon A, Rogers T, Savage K, Sawant K, Scott RH, Siddiq A, Sieghart A, Smith SC, Sosinsky A, Stuckey A, Tanguy M, Taylor Tavares AL, Thomas ERA, Thompson SR, Tucci A, Welland MJ, Williams E, Witkowska K, Wood SM, Zarowiecki M

Publikováno v: Science advances [Sci Adv] 2023 Apr 28; Vol. 9 (17), pp. eade2675. Date of Electronic Publication: 2023 Apr 28.

Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.

Autor: Saunders CN; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Cornish AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Kinnersley B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Claus EB; School of Public Health, Yale University, New Haven, Connecticut, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Il'yasova D; Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA.; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Schildkraut J; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Barnholtz-Sloan JS; Department of Population and Quantitative Health Sciences and the Cleveland Center for Health Outcomes Research, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bernstein JL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lai RK; Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Rajaraman P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Johansen C; Danish Cancer Society Research Center, Survivorship, Danish Cancer Society, Copenhagen, Denmark.; Oncology Clinic, Finsen Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA., Melin BS; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Wrensch MR; Department of Neurological Surgery, School of Medicine, University of California San Francisco (UCSF), San Francisco, California, USA.; Institute of Human Genetics, University of California San Francisco, San Francisco, California, USA., Sanson M; Sorbonne University, National Center for Scientific Research, National Institute of Health and Medical Research (INSERM), Brain and Spinal Cord Institute, Paris, France.; Department of Neurology Mazarin 2, Pitié-Salpêtrière Hospital Group, Paris, France., Bondy ML; Section of Epidemiology and Population Sciences, Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.

Publikováno v: Neuro-oncology [Neuro Oncol] 2020 Feb 20; Vol. 22 (2), pp. 207-215.

Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma.

Autor: Takahashi H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Cornish AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Sud A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Kinnersley B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Ostrom QT; Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Labreche K; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Eckel-Passow JE; Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA., Armstrong GN; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Claus EB; School of Public Health, Yale University, New Haven, Connecticut, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Il'yasova D; Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA.; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Schildkraut J; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA., Barnholtz-Sloan JS; Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bernstein JL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lai RK; Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Simon M; Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Str. 25, 53105, Bonn, Germany., Hoffmann P; Human Genomics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany., Nöthen MM; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.; Institute of Human Genetics, University of Bonn School of Medicine & University Hospital Bonn, Bonn, Germany., Jöckel KH; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA., Rajaraman P; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA., Johansen C; Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA., Melin BS; Department of Radiation Sciences, Umeå University, Umeå, Sweden., Wrensch MR; Department of Neurological Surgery, School of Medicine, University of California, San Francisco, California, USA.; Institute of Human Genetics, University of California, San Francisco, California, USA., Sanson M; Sorbonne Universités UPMC Univ Paris 06, INSERM CNRS, U1127, UMR 7225, ICM, F-75013, Paris, France.; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de neurologie 2-Mazarin, Paris, France., Bondy ML; Department of Medicine, Section of Epidemiology and Population Sciences, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; William Harvey Research Institute, Queen Mary University, London, UK.; Guys and St Thomas Foundation NHS Trust, Great Maze Pond, London, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. richard.houlston@icr.ac.uk.; Division of Molecular Pathology, The Institute of Cancer Research, London, UK. richard.houlston@icr.ac.uk.

Publikováno v: Scientific reports [Sci Rep] 2019 May 23; Vol. 9 (1), pp. 7924. Date of Electronic Publication: 2019 May 23.